Alaunos Therapeutics, Inc.·4

Apr 1, 4:30 PM ET

De Groot Eleanor 4

4 · Alaunos Therapeutics, Inc. · Filed Apr 1, 2022

Insider Transaction Report

Form 4
Period: 2022-03-30
De Groot Eleanor
EVP, GM Cell Therapy
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-30+350,000350,000 total
    Exercise: $0.66Exp: 2032-03-29Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]One-sixteenth of the shares underlying the option vest in equal quarterly installments commencing three months after January 1, 2022, subject to the Reporting Person's continued service through each such date.

Documents

2 files